We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Procter & Gamble
PG
$340B
| $9.92M | 0.01% |
59,182
-2,482
| -4% | -$423K |
|
352
Blue Bird Corp
BLBD
$2.07B
| $9.75M | 0.01% |
+252,281
| New | +$10.5M |
|
353
State Street Blackstone Senior Loan ETF
SRLN
$5.35B
| $9.64M | 0.01% |
231,121
+39,415
| +21% | +$1.65M |
|
|
NPKI
354
NPK International
NPKI
$1.15B
| $9.54M | 0.01% |
1,243,797
+39,392
| +3% | +$290K |
|
355
Hope Bancorp
HOPE
$1.79B
| $9.54M | 0.01% |
776,103
+15,410
| +2% | +$200K |
|
356
Dana Inc
DAN
$3.21B
| $9.5M | 0.01% |
+821,675
| New | +$8.53M |
|
|
SGI
357
Somnigroup International
SGI
$13.6B
| $9.3M | 0.01% |
+164,129
| New | +$8.76M |
|
358
Live Oak Bancshares
LOB
$1.95B
| $9.29M | 0.01% |
234,818
+13,555
| +6% | +$610K |
|
359
International Money Express
IMXI
$356M
| $9.29M | 0.01% |
445,778
-19,785
| -4% | -$388K |
|
360
Yeti Holdings
YETI
$3.99B
| $9.06M | 0.01% |
+235,252
| New | +$9.35M |
|
361
Lockheed Martin
LMT
$139B
| $9.01M | 0.01% |
18,548
+2,335
| +14% | +$1.27M |
|
362
Brunswick
BC
$5.21B
| $8.85M | 0.01% |
136,790
| – | – |
|
363
Globant
GLOB
$1.66B
| $8.76M | 0.01% |
40,864
-1,757
| -4% | -$383K |
|
|
ECG
364
Everus Construction Group
ECG
$6.73B
| $8.69M | 0.01% |
+132,216
| New | +$8.32M |
|
365
Sensata Technologies
ST
$6.66B
| $8.36M | 0.01% |
305,212
+32,151
| +12% | +$1.04M |
|
366
Columbus McKinnon
CMCO
$557M
| $8.23M | 0.01% |
221,104
| – | – |
|
367
Morgan Stanley
MS
$338B
| $8.12M | 0.01% |
64,552
+10,056
| +18% | +$1.24M |
|
368
Union Pacific
UNP
$174B
| $8.01M | 0.01% |
35,139
+4,302
| +14% | +$1.02M |
|
369
Hawkins
HWKN
$2.73B
| $7.94M | 0.01% |
64,750
-12,389
| -16% | -$1.56M |
|
370
Ecovyst
ECVT
$1.1B
| $7.85M | 0.01% |
1,027,606
| – | – |
|
371
Powell Industries
POWL
$7.55B
| $7.59M | 0.01% |
102,783
+5,139
| +5% | +$459K |
|
372
J&J Snack Foods
JJSF
$1.68B
| $7.3M | 0.01% |
47,061
+12,453
| +36% | +$2.09M |
|
373
iShares JPMorgan EM Corporate Bond ETF
CEMB
$412M
| $7.12M | 0.01% |
160,414
-18,610
| -10% | -$839K |
|
374
Cogent Communications
CCOI
$528M
| $7.08M | 0.01% |
+91,910
| New | +$7.33M |
|
|
SEM
375
DELISTED
Select Medical
SEM
| $6.98M | 0.01% |
370,425
-146,413
| -28% | -$2.82M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.